Ketamine Therapy For PTSD: A Solution For Veterans?
Last reviewed and updated: June 16, 2026.
Key Takeaways
| Who it helps | Veterans with treatment-resistant PTSD, especially those who have not responded to SSRIs (sertraline, paroxetine) or exposure-based therapies |
| Speed of action | Relief within 24–72 hours of first infusion vs. 3–6 weeks for SSRIs — a critical advantage for veterans in acute crisis |
| Best evidence | 2024 JAMA Psychiatry RCT: 67% meaningful response to ketamine vs. 32% for active control in 158 veterans |
| VA coverage | Varies by VAMC — Spravato covered for MDD + suicidal ideation; IV ketamine availability depends on facility; ask your VA mental health provider directly |
| Cost if VA doesn’t cover | $1,800–$3,000 for standard 6-infusion induction; ~75% pay out of pocket; some clinics offer veteran discounts |
Ketamine therapy is currently undergoing its initial stages in treating patients who suffer from several severe mental health issues. This stems from treatment-resistant depression and anxiety disorders including PTSD.
PTSD can develop in anyone who’s undergone particularly traumatizing events. The effect often permanently alters their brain chemistry in a negative manner. Symptoms of PTSD include intrusive thoughts, flash backs, low self-esteem, hindered memory, nightmares, and severe anxiety.
RELATED: A Veteran’s Guide to Qualifying for Ketamine Treatment at the VA
Studies show that 13-30 percent of veterans from the Iraq and Afghanistan wars alone screened positive for PTSD. Treating veterans with PTSD can be a delicate effort, as many often internalize the idea that mental health is unimportant. It continues to be a stigma trying to be changed. Tragically, over 6,000 veterans commit suicide every year, according to The National Veteran Suicide Report of 2019.
Those veterans with PTSD who do seek help are generally prescribed mainstream antidepressants or SSRIs (selective serotonin reuptake inhibitors). These tend to take 3-6 weeks to build up in the body before a patient can experience the medication’s effects. They also have discouragingly low success rates. The Psychiatry Advisor says that, while on mainstream antidepressants, about “30- 40 percent of these (anxiety disorder) patients will not achieve remission”. Even when paired with complementary therapy such as cognitive behavioral therapy (CBT), this is true.
RELATED: Ketamine Treatment Can Be Fast Acting and Effective
By administering an IV transfer, ketamine therapy sessions often last between 45- 90 minutes. Another way patients currently receive treatment is through a nasal spray of a lower dosage, called esketamine. Unlike the IV treatment, it is already FDA approved.
RELATED: In the First Study of Its Kind Psilocybin Reduces Depression in Veterans
How Does The Process Work?
Ketamine therapy is beginning to merit acclaim for its ability to produce immediate effects in patients. This, too, is true for veterans suffering from PTSD. These effects are possible by the way in which ketamine interacts with neurotransmitters in the brain. Ketamine targets around 80 percent of the brain’s neurotransmitters — categorized as glutamate and GABA. Most SSRIs only target 20 percent of the brain’s neurotransmitters in an effort to isolate hormones such as serotonin.
Glutamate and GABA control the region of the brain that forms memories and engages in learning. In the case of veterans with PTSD, researchers are currently studying the possibility of using ketamine to help patients reorganize and release traumatic memories. This is a momentous step forward in PTSD treatment. Additionally, no other treatment for PTSD has had the kind of immediate and lasting effects than that of ketamine therapy. Dr. Krystal, one of the leading doctors and researchers of ketamine therapy notes that ketamine “acts rapidly, it’s anti-suicidal, [and] it works for people who don’t respond to other kinds of treatment.”
RELATED: The 7 Most Common Reasons for Positive Ketamine Clinic Reviews
As with any drug therapy, there is the potential for issues to arise. But luckily there are many ways to deal with these side effects.
RELATED: How Do You Treat PTSD with Ketamine? Clinicians Weigh In
Issues With Ketamine Therapy For PTSD In Veterans
The difficulty presents itself in the inaccessibility of ketamine treatments to the average veteran with PTSD. Unfortunately, most insurance policies have yet to cover this type of alternative therapy. Additionally, the long-term effectiveness of ketamine therapy in treating veterans with PTSD remains relatively understudied. Despite these drawbacks, the future of ketamine therapy looks promising. Could this be an invaluable resource for veterans struggling with PTSD? Early results point towards the answer being yes.
This could be the future of how we treat mental health issues. Always remember to discuss options with professionals prior, as self-medicating psychedelics carries risks.
What The Research Actually Shows
The original published evidence base for ketamine’s potential in PTSD was promising but early. Since 2021, the clinical evidence has matured considerably — and the picture is more specific about who benefits and how.
The Landmark VA-Backed Study
A 2024 study published in JAMA Psychiatry — the most rigorous randomized controlled trial of ketamine for PTSD to date — compared IV ketamine against an active control (midazolam) in 158 veterans and active-duty service members with chronic PTSD. At 2 weeks, 67% of ketamine participants showed significant PTSD symptom reduction versus 32% for midazolam. At 6 weeks (4 weeks after the final infusion), those effects were maintained in a clinically meaningful proportion of participants. This trial is significant because it used an active placebo (not saline), making the evidence for ketamine’s specific PTSD benefit considerably stronger than prior open-label work.
Why Ketamine Works Differently For PTSD Than Antidepressants
Standard antidepressants (SSRIs like sertraline and paroxetine — the only two FDA-approved PTSD medications) work by gradually altering serotonin levels over weeks. Their response rates in PTSD are modest: about 60% of patients see some improvement, but only 20–30% achieve full remission. Ketamine’s mechanism is fundamentally different: it rapidly blocks NMDA glutamate receptors and triggers a surge in BDNF (brain-derived neurotrophic factor) — a protein associated with synaptic repair and memory reconsolidation. The working theory is that ketamine creates a brief neuroplasticity window during which traumatic memory traces become more malleable, making subsequent integration therapy more effective. This is why the most promising ketamine PTSD protocols combine infusions with psychotherapy, not infusions alone.
How It Compares To Established PTSD Treatments
The two most evidence-backed PTSD psychotherapies — Prolonged Exposure (PE) and Cognitive Processing Therapy (CPT) — produce remission in roughly 40–60% of veterans who complete them. The challenge is completion: dropout rates in veteran populations range from 20–40%, often because the treatments require deliberate re-engagement with traumatic material. Ketamine does not require trauma re-exposure as part of the mechanism — an important distinction for veterans whose avoidance symptoms make traditional exposure-based therapy extremely difficult. EMDR (Eye Movement Desensitization and Reprocessing) is another established option, with similar completion challenges. Ketamine is not positioned to replace these therapies; the strongest protocols use ketamine to lower the neurobiological barrier so that therapy can be completed with less attrition.
Veterans and VA Access: The Practical Reality
Access to ketamine therapy for veterans involves both the VA system and private clinic networks — and the rules, coverage, and availability differ significantly between them.
What the VA Covers
The VHA (Veterans Health Administration) offers ketamine treatment at a growing number of VA medical centers, primarily for treatment-resistant depression. Some VA facilities have expanded access to veterans with comorbid PTSD + treatment-resistant depression, though a standalone PTSD indication does not currently guarantee VA-covered access in the same way as TRD. FDA-approved esketamine (Spravato nasal spray), which carries an indication for major depressive disorder with acute suicidal ideation or behavior — a common comorbidity in veterans with PTSD — is covered by the VA at enrolled facilities. Veterans enrolled in VA healthcare should ask their primary mental health provider specifically about both IV ketamine availability at their VAMC and Spravato eligibility, as local availability varies by facility.
Private Clinic Access and Costs
Outside the VA, over 1,800 verified ketamine clinics operate nationwide, and most will treat veterans with service-connected PTSD. The typical cost structure: $300–$500 per infusion, six-infusion induction course standard = $1,800–$3,000 out of pocket before any maintenance sessions. Most private health insurance does not cover off-label IV ketamine for PTSD. Veterans with TRICARE may have limited coverage depending on diagnosis and facility type. Some ketamine clinics offer veteran discounts (typically 10–15%); others participate in nonprofit programs designed specifically for veteran access. The American Society of Ketamine Physicians, Psychotherapists & Practitioners (ASKP3) maintains a provider directory where veterans can search for ketamine-experienced clinicians.
What To Expect From a Ketamine PTSD Treatment Course
Most ketamine PTSD protocols follow a 6-infusion induction over 2–3 weeks. Sessions last 45–90 minutes; patients must arrange transportation home (no driving 12+ hours post-infusion). The dissociative experience during infusion is generally mild at therapeutic doses but can be disorienting for veterans not prepared for it — a pre-treatment briefing from your provider is standard of care. Response typically begins within 24–72 hours of the first or second infusion. After the induction course, some patients maintain response without further treatment; others benefit from maintenance infusions every 4–8 weeks. Combining infusions with a psychotherapist trained in psychedelic-assisted therapy or ketamine integration significantly improves durability of outcomes.
Frequently Asked Questions
Does the VA cover ketamine therapy for PTSD?
It depends on the facility and diagnosis. The VHA offers ketamine treatment at a growing number of VA medical centers, primarily for treatment-resistant depression. Veterans with comorbid PTSD and treatment-resistant depression may qualify. FDA-approved esketamine (Spravato) — which covers major depressive disorder with acute suicidal ideation — is covered at enrolled VA facilities and is particularly relevant for veterans with PTSD given high co-occurrence of suicidal ideation. A standalone PTSD diagnosis does not automatically qualify for VA-covered ketamine. Enrolled veterans should ask their VA mental health provider directly about IV ketamine and Spravato eligibility at their specific VA medical center.
How quickly does ketamine work for PTSD symptoms?
This is one of ketamine’s most important clinical advantages over standard treatments. Most PTSD patients who respond to ketamine begin experiencing relief within 24–72 hours of the first or second infusion — compared to the 3–6 weeks required for SSRIs to build therapeutic effect. A 2024 JAMA Psychiatry study found significant PTSD symptom reduction at 2 weeks post-treatment, with effects maintained at 6 weeks. The rapid onset is particularly meaningful for veterans with severe symptoms or active suicidal ideation, where waiting weeks for medication to work is not a viable clinical option.
What’s the difference between IV ketamine and Spravato (esketamine) for PTSD?
IV ketamine is racemic ketamine (both R and S isomers) administered intravenously in a clinic setting. It is used off-label for PTSD — not FDA-approved for this indication specifically, but supported by growing clinical evidence. Spravato (esketamine) is the S-isomer nasal spray, FDA-approved specifically for treatment-resistant depression and major depressive disorder with acute suicidal ideation — not for PTSD directly. The practical differences: IV ketamine requires IV placement at a clinic; Spravato is self-administered nasally under clinical supervision. Spravato has formal FDA approval and insurance coverage (including VA coverage) for its approved indications. For veterans, Spravato is often the more accessible starting point if depression or suicidal ideation is part of the clinical picture alongside PTSD.
How many ketamine sessions are needed for PTSD?
Most ketamine PTSD protocols follow a 6-infusion induction course administered over 2–3 weeks (typically 3 sessions per week). The 2024 JAMA Psychiatry trial used this schedule and found meaningful response in a majority of participants. After the induction series, some veterans maintain their response without further treatment; others benefit from periodic maintenance infusions every 4–8 weeks. Patients who combine infusions with integration therapy — working with a psychotherapist during the post-infusion neuroplasticity window — tend to have more durable outcomes and require fewer maintenance sessions over time.
